Format

Send to

Choose Destination
PLoS Med. 2016 May 31;13(5):e1002031. doi: 10.1371/journal.pmed.1002031. eCollection 2016 May.

A Revolution in Treatment for Hepatitis C Infection: Mitigating the Budgetary Impact.

Author information

1
Health Strategies International, Oakland, California, United States of America.
2
Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco, San Francisco, California, United States of America.

Abstract

In a Perspective accompanying Hill and colleagues, Elliot Marseille and James Kahn compare the history of pricing and availability of ART for HIV with that of the new HCV drugs and discuss strategies for providing treatment in LMIC even in the face of high costs.

PMID:
27243461
PMCID:
PMC4886960
DOI:
10.1371/journal.pmed.1002031
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Public Library of Science Icon for PubMed Central
Loading ...
Support Center